InMed Pharmaceuticals Inc (INM)

[Greengo]

Results of Operations ( from the filings )

During the year ended June 30, 2014 the Company reported a comprehensive loss of $1,229,240 and
loss per share of $0.04 compared to a comprehensive loss of $49,175 and loss per share of $0.00
reported in the comparative year ended June 30, 2013. The primary component of the loss was related
to the recording of share-based payments of $711,436 (June 30, 2013 - $Nil) in connection with the
grant of stock options. Additionally there was an increase in general and administration expenses of
$456,118 (June 30, 2013 - $49,186) and research and development of $61,744 (June 30, 2013 - $Nil) as
result of the Company’s change of business into the Life Science Sector.